These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 13943861)

  • 1. Protective activity of cholera vaccines against E1 Tor cholera vibrios.
    PITTMAN M; FEELEY JC
    Bull World Health Organ; 1963; 28(3):379-83. PubMed ID: 13943861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled field trial of the effectiveness of monovalent classical and El Tor cholera vaccines in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1973; 49(1):13-9. PubMed ID: 4596491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Vibrio cholerae from nightsoil during epidemics of classical and E1 Tor Cholera in East Pakistan.
    Bart KJ; Khan M; Mosley WH
    Bull World Health Organ; 1970; 43(3):421-9. PubMed ID: 5312997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRELIMINARY STUDIES ON THE DEVELOPMENT OF A LIVE ORAL VACCINE FOR ANTI-CHOLERA IMMUNIZATION.
    MUKERJEE S
    Bull World Health Organ; 1963; 29(6):753-66. PubMed ID: 14107748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.
    Azurin JC; Cruz A; Pesigan TP; Alvero M; Camena T; Suplido R; Ledesma L; Gomez CZ
    Bull World Health Organ; 1967; 37(5):703-27. PubMed ID: 5300874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory studies on the El Tor vibrio.
    SAYAMOV RM
    Bull World Health Organ; 1963; 28(3):311-25. PubMed ID: 13986981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
    Tacket CO; Losonsky G; Nataro JP; Cryz SJ; Edelman R; Kaper JB; Levine MM
    J Infect Dis; 1992 Oct; 166(4):837-41. PubMed ID: 1527420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and laboratory tests of oil-adjuvant cholera vaccine.
    Ogonuki H; Hashizume S; Takashashi B
    Bull World Health Organ; 1967; 37(5):729-36. PubMed ID: 5300875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE 1961 CHOLERA EPIDEMIC IN MANILA, REPUBLIC OF THE PHILIPPINES.
    WALLACE CK; FABIE AE; MANGUBAT O; VELASCO E; JUINIO C; PHILLIPS RA
    Bull World Health Organ; 1964; 30(6):795-810. PubMed ID: 14215186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines. Preliminary report; Philippines Cholera Committee.
    Philippines Cholera Committee
    Bull World Health Organ; 1965; 32(5):603-25. PubMed ID: 5294176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Vibrio cholerae and Vibrio El Tor.
    Basu S; Bhattacharya P; Mukerjee S
    Bull World Health Organ; 1966; 34(3):371-8. PubMed ID: 5296397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFFECT OF MUKERJEE'S GROUP IV PHAGE ON EL TOR VIBRIOS.
    MONSUR KA; RIZVI SS; HUQ MI; BENENSON AS
    Bull World Health Organ; 1965; 32(2):211-6. PubMed ID: 14310908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.
    Guentzel MN; Berry LJ
    Infect Immun; 1974 Jul; 10(1):167-72. PubMed ID: 4601899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.